579 related articles for article (PubMed ID: 34656878)
1. Lactate in the tumour microenvironment: From immune modulation to therapy.
Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
[TBL] [Abstract][Full Text] [Related]
2. The Immune Consequences of Lactate in the Tumor Microenvironment.
Harmon C; O'Farrelly C; Robinson MW
Adv Exp Med Biol; 2020; 1259():113-124. PubMed ID: 32578174
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.
Hayes C; Donohoe CL; Davern M; Donlon NE
Cancer Lett; 2021 Mar; 500():75-86. PubMed ID: 33347908
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Warburg Effect in Cancer: Where Do We Stand?
Barba I; Carrillo-Bosch L; Seoane J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542116
[TBL] [Abstract][Full Text] [Related]
5. Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.
Pereira-Nunes A; Afonso J; Granja S; Baltazar F
Adv Exp Med Biol; 2020; 1219():51-74. PubMed ID: 32130693
[TBL] [Abstract][Full Text] [Related]
6. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
[TBL] [Abstract][Full Text] [Related]
7. Metabolic profiles of regulatory T cells in the tumour microenvironment.
Rao D; Verburg F; Renner K; Peeper DS; Lacroix R; Blank CU
Cancer Immunol Immunother; 2021 Sep; 70(9):2417-2427. PubMed ID: 33576875
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy.
Peng X; He Y; Huang J; Tao Y; Liu S
Front Immunol; 2021; 12():613492. PubMed ID: 33732237
[TBL] [Abstract][Full Text] [Related]
9. Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.
Traba J; Sack MN; Waldmann TA; Anton OM
Front Immunol; 2021; 12():657293. PubMed ID: 34079545
[TBL] [Abstract][Full Text] [Related]
10. The cancer metabolic reprogramming and immune response.
Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
[TBL] [Abstract][Full Text] [Related]
11. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
12. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
[TBL] [Abstract][Full Text] [Related]
13. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
[TBL] [Abstract][Full Text] [Related]
14. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Jiang Z; Liu Z; Li M; Chen C; Wang X
EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
[TBL] [Abstract][Full Text] [Related]
15. The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma.
Reuss AM; Groos D; Buchfelder M; Savaskan N
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073734
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
Marchiq I; Pouysségur J
J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
[TBL] [Abstract][Full Text] [Related]
17. Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy.
Shen L; Xiao Y; Tian J; Lu Z
Cancer Lett; 2022 Mar; 529():139-152. PubMed ID: 35007698
[TBL] [Abstract][Full Text] [Related]
18. Tumor stroma interaction is mediated by monocarboxylate metabolism.
Patel BB; Ackerstaff E; Serganova IS; Kerrigan JE; Blasberg RG; Koutcher JA; Banerjee D
Exp Cell Res; 2017 Mar; 352(1):20-33. PubMed ID: 28132882
[TBL] [Abstract][Full Text] [Related]
19. Role of Lactate in Inflammatory Processes: Friend or Foe.
Manosalva C; Quiroga J; Hidalgo AI; Alarcón P; Anseoleaga N; Hidalgo MA; Burgos RA
Front Immunol; 2021; 12():808799. PubMed ID: 35095895
[TBL] [Abstract][Full Text] [Related]
20. Monocarboxylate transporters in cancer.
Payen VL; Mina E; Van Hée VF; Porporato PE; Sonveaux P
Mol Metab; 2020 Mar; 33():48-66. PubMed ID: 31395464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
